Great Point Partners’s Tetraphase Pharmaceuticals TTPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TTPH
Great Point Partners's TTPH Position: Q4 2016 in Review
Great Point Partners sold out of Tetraphase Pharmaceuticals (TTPH) in Q4 2016, closing a stake of 22,619 shares — an estimated $1.73M sold.
Great Point Partners first reported a position in TTPH in Q3 2015 and held it in 5 quarters. The position peaked at $19.5M in Q4 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.
- Great Point Partners reported no remaining Tetraphase Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Great Point Partners sold 22,619 Tetraphase Pharmaceuticals shares in Q4 2016, an estimated $1.73M.
- Great Point Partners first reported a position in Tetraphase Pharmaceuticals in Q3 2015 and held it in 5 quarters.
- Great Point Partners's Tetraphase Pharmaceuticals position peaked at $19.5M in Q4 2015.
- 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals as of Q4 2016.
Based on Great Point Partners's 13F filing for Q4 2016, filed 14 Feb 2017.